Product Information
VARENICLINE STARTING MONTH BOX is a generic product labeled by Ascend Laboratories, LLC, priced at $0.3972 per EA under NDC 67877074554. Its NADAC has been published 152 times since Nov 8, 2023.
FDA first approved this application on Aug 23, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Ascend Laboratories, LLCNDC
67877074554
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA214557FDA Approved
8/23/2023
TE Code
AB
On Market Since
8/25/2023
Price Statistics
The NADAC for VARENICLINE STARTING MONTH BOX has been published 152 times since Nov 8, 2023, and over the history we have for it it has declined 93.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3972 per EA |
|---|---|
| All-time high | $6.5609 (Nov 15, 2023) |
| All-time low | $0.3972 (Sep 23, 2026) |
| 52-week high | $0.5229 |
| 52-week low | $0.3972 |
| Median price | $0.6097 |
| Average price | $1.3838 |
| Largest weekly change | +71.9% (Dec 18, 2024) |
| Weeks tracked | 152 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Varenicline tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VARENICLINE STARTING MONTH BOX?
The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE STARTING MONTH BOX, manufactured by Ascend Laboratories, LLC, is $0.3972 per EA (NDC 67877074554), effective Sep 30, 2026.
How has the price of VARENICLINE STARTING MONTH BOX changed over time?
Over the history we have for it, the NADAC for VARENICLINE STARTING MONTH BOX has declined 93.9%. It has been tracked across 152 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for VARENICLINE STARTING MONTH BOX?
Since Nov 8, 2023, the NADAC for VARENICLINE STARTING MONTH BOX has ranged from a low of $0.3972 (Sep 23, 2026) to a high of $6.5609 (Nov 15, 2023), with a median of $0.6097 per EA.
Are there cheaper alternatives to VARENICLINE STARTING MONTH BOX?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VARENICLINE STARTING MONTH BOX in a comparable dosage form, but none are currently priced below it.
Who manufactures VARENICLINE STARTING MONTH BOX?
VARENICLINE STARTING MONTH BOX (NDC 67877074554) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.